Search research articles
Contact Us
Filters
Showing results (171-180 of 194) with videos related to
Page
of 20
Sort By:
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
March 1, 2011
[Intraoperative molecular assessment of sentinel nodes in the breast cancer using the Gene Search BLN Assay technique: our experience about 126 patients]
J-L Houpeau, M-C Baranzelli, S Giard, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1988
Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease
J P Peyrat, J Bonneterre, J C Laurent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2005
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results
P Fumoleau, H Roché, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2005
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group
M Campone, H Roché, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2006
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial
H Roché, P Kerbrat, J Bonneterre, et al.
British Journal of Cancer
|
August 1, 1996
A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor
I Smith, A Jones, M Spielmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes
P Fumoleau, F Chauvin, M Namer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2000
High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment
S Kvinnsland, G Anker, L Y Dirix, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma
P Rougier, A Adenis, M Ducreux, et al.
Anti-Cancer Drugs
|
August 13, 2002
Effects of impaired renal function on the pharmacokinetics and toxicity of i.v. ZD9331, a novel non-polyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors
Maja J A de Jonge, B Glimelius, Jaap Verweij, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 194) with videos related to
Sort By:
Page
of 20
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
March 1, 2011
[Intraoperative molecular assessment of sentinel nodes in the breast cancer using the Gene Search BLN Assay technique: our experience about 126 patients]
J-L Houpeau, M-C Baranzelli, S Giard, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1988
Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease
J P Peyrat, J Bonneterre, J C Laurent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2005
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results
P Fumoleau, H Roché, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2005
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group
M Campone, H Roché, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2006
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial
H Roché, P Kerbrat, J Bonneterre, et al.
British Journal of Cancer
|
August 1, 1996
A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor
I Smith, A Jones, M Spielmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes
P Fumoleau, F Chauvin, M Namer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2000
High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment
S Kvinnsland, G Anker, L Y Dirix, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma
P Rougier, A Adenis, M Ducreux, et al.
Anti-Cancer Drugs
|
August 13, 2002
Effects of impaired renal function on the pharmacokinetics and toxicity of i.v. ZD9331, a novel non-polyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors
Maja J A de Jonge, B Glimelius, Jaap Verweij, et al.
Page
of 20